Lessee, Operating Lease, Liability, to be Paid, Year One in USD of Unity Biotechnology, Inc. from Q2 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Unity Biotechnology, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q2 2020 to Q1 2025.
  • Unity Biotechnology, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending March 31, 2025 was $5.29M, a 3.2% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Unity Biotechnology, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $5.29M +$164K +3.2% Mar 31, 2025 10-Q 2025-04-22
Q4 2024 $5.12M +$159K +3.2% Dec 31, 2024 10-K 2025-03-07
Q3 2024 $5.12M +$159K +3.2% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $5.12M +$159K +3.2% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.12M +$159K +3.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.96M +$154K +3.2% Dec 31, 2023 10-K 2024-04-15
Q3 2023 $4.96M +$154K +3.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4.96M +$154K +3.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4.96M +$154K +3.2% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $4.81M -$1.48M -23.5% Dec 31, 2022 10-K 2023-03-15
Q3 2022 $4.81M -$1.47M -23.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.81M -$1.47M -23.4% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $4.81M -$1.47M -23.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.29M -$367K -5.52% Dec 31, 2021 10-K 2022-03-15
Q3 2021 $6.28M -$370K -5.56% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $6.28M -$370K -5.56% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $6.28M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $6.65M Dec 31, 2020 10-K 2021-03-23
Q3 2020 $6.65M Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $6.65M Jun 30, 2020 10-Q 2020-07-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.